))
Magnesium: The ‘Best’ Form Isn’t What You Think Part 2
Manage episode 521419685 series 3635277
Magnesium salts are often marketed as if they target specific tissues - i.e., “threonate for the brain,” “glycinate for calm,” “taurate for the heart.” Part 2 breaks down what the evidence actually shows: animal studies demonstrating tissue differences that have never been replicated in humans, cognitive and sleep trials where multiple forms show benefit, and meta-analytic data indicating what really drives long-term outcomes.
The goal: clarify the real distinctions between magnesium forms, ligand effects, and dose requirements so listeners can understand what truly determines magnesium’s impact in humans.
00:00 Introduction to Magnesium Forms
00:22 Zooming Out: Broader Human Data
01:08 Systematic Reviews and Meta-Analyses
02:10 Key Findings on Magnesium Benefits
04:05 Understanding Magnesium Salts and Ligands
07:13 Practical Applications and Recommendations
09:32 Conclusion and Final Thoughts
- Doi: 10.1186/s40795-016-0121-3
- PMID: 11550076
- PMID: 31330811
- PMID: 39252819
- PMID: 26519439
- PMID: 34111673
- PMID: 23853635
- doi: 10.3390/nu9050429
- PMID: 39009081
Chapters
1. Revisiting Forms And Absorption (00:00:00)
2. Human Trials Show Broad Benefits (00:00:51)
3. Cognitive Evidence And Dose Ranges (00:02:10)
4. Separating Magnesium From The Ligand (00:04:00)
5. What Predicts Long‑Term Benefits (00:06:06)
6. Practical Buying And Dosing Advice (00:07:13)
7. Final Takeaways And Listener Requests (00:09:10)
71 episodes
Share
